Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.
2.

Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.

Carter CJ.

Neurochem Int. 2008 May;52(6):920-34. doi: 10.1016/j.neuint.2007.11.003. Epub 2007 Nov 23. Review.

PMID:
18164103
3.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
4.

Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.

Poirier J.

Ann N Y Acad Sci. 2000;924:81-90. Review.

PMID:
11193807
5.

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W.

Semin Vasc Med. 2004 Aug;4(3):279-85. Review.

PMID:
15630629
6.

Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT.

Brain Res. 2007 Aug 3;1161:116-23. Epub 2007 Jun 5.

PMID:
17586478
7.

[Alzheimer's disease. Present and future role of genetics].

Roks G.

Tijdschr Gerontol Geriatr. 2003 Feb;34(1):13-20. Dutch.

PMID:
12629906
8.

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.

Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN.

J Neurochem. 2009 Dec;111(6):1275-308. Review.

PMID:
20050287
9.

APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.

Carter CJ.

Neurosci Lett. 2010 Oct 11;483(2):96-100. doi: 10.1016/j.neulet.2010.07.066. Epub 2010 Jul 30. Review.

PMID:
20674675
10.

LRP1 modulates APP trafficking along early compartments of the secretory pathway.

Waldron E, Heilig C, Schweitzer A, Nadella N, Jaeger S, Martin AM, Weggen S, Brix K, Pietrzik CU.

Neurobiol Dis. 2008 Aug;31(2):188-97. doi: 10.1016/j.nbd.2008.04.006. Epub 2008 May 3.

PMID:
18559293
11.

Functional interactions of APP with the apoE receptor family.

Hoe HS, Rebeck GW.

J Neurochem. 2008 Sep;106(6):2263-71. doi: 10.1111/j.1471-4159.2008.05517.x. Epub 2008 Jun 28. Review.

12.

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.

Riemenschneider M, Mahmoodzadeh S, Eisele T, Klopp N, Schwarz S, Wagenpfeil S, Diehl J, Mueller U, Foerstl H, Illig T, Kurz A.

Neurobiol Aging. 2004 Nov-Dec;25(10):1305-8.

PMID:
15465627
13.

Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).

Nowotny P, Simcock X, Bertelsen S, Hinrichs AL, Kauwe JS, Mayo K, Smemo S, Morris JC, Goate A.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):469-74.

PMID:
17427190
14.

Pharmacogenomics in Alzheimer's disease.

Cacabelos R.

Mini Rev Med Chem. 2002 Feb;2(1):59-84. Review.

PMID:
12369958
15.

[Molecular basics of Alzheimer's disease].

Grigorenko AP, Rogaev EI.

Mol Biol (Mosk). 2007 Mar-Apr;41(2):331-45. Review. Russian.

PMID:
17514900
16.
17.

LRP and Alzheimer's disease.

Zerbinatti CV, Bu G.

Rev Neurosci. 2005;16(2):123-35. Review.

PMID:
15959937
18.

Genetic study of Sardinian patients with Alzheimer's disease.

Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A.

Neurosci Lett. 2006 May 1;398(1-2):124-8. Epub 2006 Jan 19.

PMID:
16423463
19.

Cholesterol in Alzheimer's disease and other amyloidogenic disorders.

Harris JR, Milton NG.

Subcell Biochem. 2010;51:47-75. doi: 10.1007/978-90-481-8622-8_2. Review.

PMID:
20213540
20.

[Cholesterol and Alzheimer's disease].

Kálmán J, Janka Z.

Orv Hetil. 2005 Sep 11;146(37):1903-11. Review. Hungarian.

PMID:
16255374

Supplemental Content

Support Center